Literature DB >> 9621073

Structural and antigenic analysis of a truncated form of the herpes simplex virus glycoprotein gH-gL complex.

T Peng1, M Ponce de Leon, M J Novotny, H Jiang, J D Lambris, G Dubin, P G Spear, G H Cohen, R J Eisenberg.   

Abstract

The herpes simplex virus (HSV) gH-gL complex is essential for virus infectivity and is a major antigen for the host immune system. The association of gH with gL is required for correct folding, cell surface trafficking, and membrane presentation of the complex. Previously, a mammalian cell line was constructed which produces a secreted form of gHt-gL complex lacking the transmembrane and cytoplasmic tail regions of gH. gHt-gL retains a conformation similar to that of its full-length counterpart in HSV-infected cells. Here, we examined the structural and antigenic properties of gHt-gL. We first determined its stoichiometry and carbohydrate composition. We found that the complex consists of one molecule each of gH and gL. The N-linked carbohydrate (N-CHO) site on gL and most of the N-CHO sites on gH are utilized, and both proteins also contain O-linked carbohydrate and sialic acid. These results suggest that the complex is processed to the mature form via the Golgi network prior to secretion. To determine the antigenically active sites of gH and gL, we mapped the epitopes of a panel of gH and gL monoclonal antibodies (MAbs), using a series of gH and gL C-terminal truncation variant proteins produced in transiently transfected mammalian cells. Sixteen gH MAbs (including H6 and 37S) reacted with the N-terminal portion of gH between amino acids 19 and 276. One of the gH MAbs, H12, reacted with the middle portion of gH (residues 476 to 678). Nine gL MAbs (including 8H4 and VIII 62) reacted with continuous epitopes within the C-terminal portion of gL, and this region was further mapped within amino acids 168 to 178 with overlapping synthetic peptides. Finally, plasmids expressing the gH and gL truncations were employed in cotransfection assays to define the minimal regions of both gH and gL required for complex formation and secretion. The first 323 amino acids of gH and the first 161 amino acids of gL can form a stable secreted hetero-oligomer with gL and gH792, respectively, while gH323-gL168 is the smallest secreted hetero-oligomer. The first 648 amino acids of gH are required for reactivity with MAbs LP11 and 53S, indicating that a complex of gH648-gL oligomerizes into the correct conformation. The data suggest that both antigenic activity and oligomeric structure require the amino-terminal portions of gH and gL.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9621073      PMCID: PMC110415     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry.

Authors:  J C Whitbeck; C Peng; H Lou; R Xu; S H Willis; M Ponce de Leon; T Peng; A V Nicola; R I Montgomery; M S Warner; A M Soulika; L A Spruce; W T Moore; J D Lambris; P G Spear; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM.

Authors:  A V Nicola; M Ponce de Leon; R Xu; W Hou; J C Whitbeck; C Krummenacher; R I Montgomery; P G Spear; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion.

Authors:  W H Cai; B Gu; S Person
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

4.  Characterisation and physical mapping of an HSV-1 glycoprotein of approximately 115 X 10(3) molecular weight.

Authors:  E A Buckmaster; U Gompels; A Minson
Journal:  Virology       Date:  1984-12       Impact factor: 3.616

5.  The structure of an antigenic determinant in a protein.

Authors:  I A Wilson; H L Niman; R A Houghten; A R Cherenson; M L Connolly; R A Lerner
Journal:  Cell       Date:  1984-07       Impact factor: 41.582

6.  Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4.

Authors:  S D Showalter; M Zweig; B Hampar
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

7.  Variability of herpes simplex virus 1 gL and anti-gL antibodies that inhibit cell fusion but not viral infectivity.

Authors:  M J Novotny; M L Parish; P G Spear
Journal:  Virology       Date:  1996-07-01       Impact factor: 3.616

8.  Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor.

Authors:  R J Geraghty; C Krummenacher; G H Cohen; R J Eisenberg; P G Spear
Journal:  Science       Date:  1998-06-05       Impact factor: 47.728

9.  A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus.

Authors:  M S Warner; R J Geraghty; W M Martinez; R I Montgomery; J C Whitbeck; R Xu; R J Eisenberg; G H Cohen; P G Spear
Journal:  Virology       Date:  1998-06-20       Impact factor: 3.616

10.  Glycoproteins gB, gD, and gHgL of herpes simplex virus type 1 are necessary and sufficient to mediate membrane fusion in a Cos cell transfection system.

Authors:  A Turner; B Bruun; T Minson; H Browne
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

View more
  49 in total

1.  Assembly and organization of glycoproteins B, C, D, and H in herpes simplex virus type 1 particles lacking individual glycoproteins: No evidence for the formation of a complex of these molecules.

Authors:  G Rodger; J Boname; S Bell; T Minson
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 2.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

3.  Crystal structure of the Epstein-Barr virus (EBV) glycoprotein H/glycoprotein L (gH/gL) complex.

Authors:  Hisae Matsuura; Austin N Kirschner; Richard Longnecker; Theodore S Jardetzky
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-13       Impact factor: 11.205

4.  Glycoprotein D receptor-dependent, low-pH-independent endocytic entry of herpes simplex virus type 1.

Authors:  Richard S B Milne; Anthony V Nicola; J Charles Whitbeck; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

5.  The herpesvirus glycoproteins B and H.L are sequentially recruited to the receptor-bound gD to effect membrane fusion at virus entry.

Authors:  Tatiana Gianni; Cristina Forghieri; Gabriella Campadelli-Fiume
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-14       Impact factor: 11.205

6.  Intracellular trafficking and maturation of herpes simplex virus type 1 gB and virus egress require functional biogenesis of multivesicular bodies.

Authors:  Arianna Calistri; Paola Sette; Cristiano Salata; Enrico Cancellotti; Cristina Forghieri; Alessandra Comin; Heinrich Göttlinger; Gabriella Campadelli-Fiume; Giorgio Palù; Cristina Parolin
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

7.  Mutations in the amino terminus of herpes simplex virus type 1 gL can reduce cell-cell fusion without affecting gH/gL trafficking.

Authors:  Wenbo Zhou; Feng Chen; Yuri Klyachkin; Yuk Y Sham; Robert J Geraghty
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

8.  Insertional mutations in herpes simplex virus type 1 gL identify functional domains for association with gH and for membrane fusion.

Authors:  Qing Fan; Erick Lin; Patricia G Spear
Journal:  J Virol       Date:  2009-09-02       Impact factor: 5.103

9.  Hydrophobic alpha-helices 1 and 2 of herpes simplex virus gH interact with lipids, and their mimetic peptides enhance virus infection and fusion.

Authors:  Tatiana Gianni; Romana Fato; Christian Bergamini; Giorgio Lenaz; Gabriella Campadelli-Fiume
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

10.  Intracellular processing of human herpesvirus 6 glycoproteins Q1 and Q2 into tetrameric complexes expressed on the viral envelope.

Authors:  Pilailuk Akkapaiboon; Yasuko Mori; Tomohiko Sadaoka; Sayoko Yonemoto; Koichi Yamanishi
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.